Neuropathic Pain Management in Dilated Cardiomyopathy Patients

First-Line Medications

The American College of Cardiology recommends pregabalin and gabapentin as first-line medications for neuropathic pain in dilated cardiomyopathy patients due to their efficacy and favorable cardiovascular safety profile 1, 2
Gabapentin is an effective alternative to pregabalin, with similar efficacy but may require more frequent dosing, and both medications have minimal cardiac effects and are generally well-tolerated in patients with cardiac disease 3, 2

The American College of Cardiology suggests that tricyclic antidepressants (TCAs) should be used with extreme caution or avoided in dilated cardiomyopathy patients due to potential cardiac risks 1, 2
If TCAs must be used, the American Heart Association recommends obtaining a screening ECG first, starting at low doses, and limiting doses to less than 100 mg/day, and avoiding medications that may worsen heart failure symptoms or interact with cardiac medications 1, 3

Patients with dilated cardiomyopathy often have restrictive physiology and may be sensitive to medications that cause fluid retention, according to the American College of Cardiology 1
The American Heart Association recommends avoiding medications that may worsen orthostatic hypotension, which can be problematic in patients with heart failure 1, 3

The American College of Cardiology recommends evaluating the effectiveness of therapy after at least 2 weeks at therapeutic doses, and monitoring for peripheral edema, weight gain, and worsening heart failure symptoms 2, 3
The American Heart Association suggests assessing for drug interactions with cardiac medications 3, 2